Jichen Wang

Dr. Jichen Wang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
MXMaolin Xu
Maolin Xu
SLShan Lang
Shan Lang
JWJichen Wang
Jichen Wang
LHLiang Huang
Liang Huang
MWMeng Wang
Meng Wang
HZHaiyan Zhu
Haiyan Zhu
Sports-related injuries present challenges across training, acute care, and rehabilitation, and largely rely on episodic, subjective, and delayed assessment methods. Wearable sensor technologies have emerged as powerful tools for objective monitoring of biomechanical and physiological parameters, offering new opportunities to enhance the entire sports injury management continuum. While prior research has explored the function for sports monitoring and injury prevention, the potential role of wearable sensors in the entire clinical pathway covering acute injury assessment, emergency clinical decision-making and rehabilitation guidance remains insufficiently integrated. This review synthesizes current advances in wearable sensor technologies, including inertial measurement units, pressure sensors, surface electromyography, cardiovascular monitoring, biochemical sweat sensing, and emerging self-powered and textile-integrated systems. Another main part of this review is the proposal of a wearable sensor–driven emergency clinical decision framework that integrates multimodal sensor data with clinically interpretable indicators to support risk assessment, early triage, treatment suggestions, and rehabilitation management. We also analyze the key challenges related to data integration and interpretation barriers, clinical implementation, ethical, privacy, and regulatory considerations. In the end, we look forward to the future of wearable sensors in data-driven, timely, and personalized sports injury care at the intersection of sports and emergency medicine.

21 July 2023 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
JWJichen Wang
Jichen Wang
JYJiali Ye
Jiali Ye
XZXupeng Zhao
Xupeng Zhao
XLXiubin Li
Xiubin Li
XMXin Ma
Xin Ma
Background: Inflammation is considered to be one of the driving factors of cancer, and chronic inflammation plays a crucial role in tumor growth and metastasis. The aim of this study was to examine the predictive value of preoperative inflammatory biomarkers for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC), including preoperative neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and aspartate aminotransferase-to-lymphocyte ratio (ALR), a novel inflammatory biomarker. Method: This study included 198 patients with mRCC from a single center from 2006 to 2022. The optimal cut-off levels for the three biomarkers were derived using the receiver operating characteristic curve (ROC). Cox univariate and multivariate analyses were used to assess independent prognostic inflammatory biomarkers. Finally, independent prognostic inflammatory biomarkers were incorporated into the prognostic model to establish a nomogram to predict the postoperative survival of patients with mRCC. Result: The area under the ROC curve for NLR, LMR, and ALR, respectively, is 0.71 (CI: 0.635–0.784), 0.68 (CI: 0.604–0.755), and 0.75 (CI: 0.680–0.819). The optimal LMR, NLR, and ALR cut-off levels as evaluated by the ROC curve were 3.836, 3.106, and 68.056, respectively. Patients with NLR and ALR higher than the cut-off level and LMR lower than the cut-off level had a significant relationship with OS. Multivariate analysis revealed that tumor necrosis, lower LMR, and higher ALR were independent risk factors for OS. In addition, a nomogram that includes independent prognostic inflammatory biomarkers can accurately predict the OS in patients with mRCC. Conclusion: ALR and LMR are independent risk factors for the prognosis of individuals with mRCC. By monitoring ALR and LMR postoperatively, the prognosis of patients with mRCC can be better evaluated.